Imbio RV/LV Software vs ZEUS System
AI Verdict
Choose Imbio RV/LV Software if…
Choose Imbio RV/LV Software if your primary need is rapid, automated assessment of right and left ventricular strain from existing CTPA scans. This tool is ideal for aiding in the risk stratification of patients presenting with acute pulmonary conditions, such as suspected pulmonary embolism, by providing a crucial RV/LV ratio. It streamlines the workflow for radiologists and cardiologists by automatically generating measurements and reports without manual intervention.
View Imbio RV/LV Software →Choose ZEUS System if…
Choose the ZEUS System if you require long-term, continuous cardiac monitoring to detect and characterize intermittent or asymptomatic arrhythmias. This AI-powered solution is best suited for patients needing extended ECG surveillance, such as those with suspected Atrial Fibrillation or post-ablation follow-up, leveraging wearable biosensors for comprehensive data collection. It provides valuable insights into cardiac rhythm over an extended period, which might be missed by shorter-term monitoring methods.
View ZEUS System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio RV/LV Software | ZEUS System |
|---|---|---|
| Pricing | Unknown | Not disclosed |
| Deployment | Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27] | Cloud-based (AWS EC2 platform), no on-premise hardware. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Imbio RV/LV SoftwareTool A emphasizes a 'fully automated workflow' with 'no user intervention required after scan completion' and direct integration with standard PACS environments, streamlining the radiologist's workflow. While Tool B offers good integration, Tool A's automation directly minimizes user effort for its primary clinical user.
Clinical Value
TieBoth tools offer significant clinical value in their respective domains. Tool A provides critical, time-sensitive risk stratification for acute pulmonary conditions like pulmonary embolism by automating RV/LV ratio measurements. Tool B offers long-term, continuous monitoring for early and accurate arrhythmia detection, which is crucial for managing chronic cardiac conditions and preventing adverse events.
Pricing & Value
Imbio RV/LV SoftwareTool A provides transparency regarding its pricing model, stating it is subscription-based and determined by the number of analyses and installations. Tool B, in contrast, does not disclose any pricing details, making it impossible to assess its value proposition.
Enterprise Readiness
Imbio RV/LV SoftwareTool A demonstrates superior enterprise readiness with flexible deployment options, including cloud, on-premise, and integration via numerous partner platforms. It also supports DICOM compliant input/output and PACS integration. Tool B is limited to cloud-based deployment, which may not suit all enterprise IT strategies.
Innovation
ZEUS SystemTool B exhibits greater innovation by integrating AI with wearable biosensors for continuous, long-term cardiac monitoring and the detection of both symptomatic and asymptomatic arrhythmias. This pushes the boundaries of remote patient monitoring and proactive diagnostics more significantly than Tool A's application of AI to automated image measurements, which is a more established area.
Support & Docs
ZEUS SystemiRhythm (developer of ZEUS System) provides a comprehensive and publicly accessible support infrastructure, including dedicated sections on its website for both clinicians and patients, offering FAQs, troubleshooting guides, and contact information for their Zio products which integrate with ZEUS. Imbio also offers customer and technical support, but iRhythm's resources appear more extensive and readily available for a broader user base.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio RV/LV Software | ZEUS System |
|---|---|---|
| Name | Imbio RV/LV Software | ZEUS System |
| Company | Imbio | iRhythm Technologies |
| Description | AI-powered tool that automatically measures right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism. | AI-powered software that analyzes ECG data from wearable biosensors for long-term continuous cardiac monitoring, aiding in the detection and characterization of arrhythmias like Atrial Fibrillation. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Key Features | Automated measurement of right and left ventricular diameters, Calculation and reporting of RV/LV ratio, Artificial intelligence algorithm for ventricle identification and measurement, Provides annotated images showing ventricular measurements, Generates summary PDF reports, Fully automated workflow, no user intervention required after scan completion, DICOM compliant input and output, Integration with standard reading environments (PACS). | AI-powered arrhythmia detection, Continuous ECG monitoring (up to 14 days), Cloud-based data analytics, Detection and characterization of Atrial Fibrillation (AFib), Preliminary report generation for physicians, Integration with Zio Watch and Zio monitors, Support for symptomatic and asymptomatic cardiac events, HL7-based EHR integration. |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Imbio RV/LV Software and ZEUS System.
Frequently Asked Questions
More Comparisons
More matchups featuring Imbio RV/LV Software or ZEUS System
Backers
Who funded each tool's parent company.